Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Case Reports in Oncology|July 19, 2012
Complete and sustained objective response per RECIST to Irvalec (PM02734) in undifferentiated large cell esophageal adenocarcinoma: A case report and a review of the literatureRamón Salazar, Carmen Cuadra, Marta Gil-Martín, et al.
Gynecologic Oncology|January 2, 2017
Molecular approaches for classifying endometrial carcinomaJosep M Piulats, Esther Guerra, Marta Gil-Martín, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2014
Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumorsRamon Salazar, Serafin Morales, Marta Gil-Martín, et al.
International Journal of Molecular Sciences|August 1, 2017
TGFβ Controls Ovarian Cancer Cell ProliferationElisenda Alsina-Sanchís, Agnès Figueras, Alvaro Lahiguera, et al.
Journal of Pain and Symptom Management|February 11, 2026
Early Supportive vs Standard Care in Phase I Cancer Trials: A Randomized Controlled TrialAnna Casellas-Grau, Claudia Cruz-Sequeiros, Sílvia Sala-Suñé, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumoursLaura Vidal, Ivan Victoria, Lydia Gaba, et al.
Cancers|September 23, 2022
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse SettingMargarita Romeo, Marta Gil-Martín, Lydia Gaba, et al.
Journal for Immunotherapy of Cancer|March 26, 2022
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumorsRocio Garcia-Carbonero, Miriam Bazan-Peregrino, Marta Gil-Martín, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 8, 2026
Addressing unmet needs in long-term survivors of ovarian cancer (ENGOT ov40/NOGGO S13/GEICO 71-R/Expression VI): insights from a Spanish cohortMaria-Pilar Barretina-Ginesta, Ainhoa Madariaga, Marta Gil-Martín, et al.
Pageof 1